Skip to main content

Closed

CING: Cingulate Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-91.9%

Financially safe

Strong

Debt / equity0.39×

Interest coverage17.7×

Current ratio2.55×

Cingulate Inc.

CINGNASDAQ Capital Market·USD·Closed

Cingulate Inc.

CINGNASDAQ·USD·Closed

$4.79

+0.63%

$4.79

+$0.03 (0.63%)

52W Range

19thpctl

Volume

0.12×avg

Mkt Cap

26.85MUSD

P/E

-1.0TTM

Div Yield

–ann

52W Range

19thpctl

Volume

0.12×avg

Market Cap

26.85MUSD

P/E Ratio

-1.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings